Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Dermatol ; 46(9): 812-815, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31271447

RESUMO

A 3-month-old boy developed small papules on his trunk. After the papules increased in number, the patient was diagnosed with Langerhans cell histiocytosis based on the pathological findings. He was referred to our department for further examination. Upon initial examination, the papules and nodules were scattered on his back, abdomen and lumbar region. Because he did not present with any organ involvement except the skin, he was diagnosed with single-system and skin-limited Langerhans cell histiocytosis. Skin rashes were treated with a topical steroid and started regressing 3 months after onset. All papules disappeared 6 months after onset. In this boy, the Langerhans cell histiocytosis tumor cells expressed phosphorylated extracellular signal-regulated kinases. In Langerhans cell histiocytosis, BRAF V600E and other genes are known to mutate to act as driver mutations in stem cells of the myeloid dendritic cell lineage. Consequently, extracellular signal-regulated kinases are continuously activated, which contributes to Langerhans cell histiocytosis carcinogenesis.


Assuntos
MAP Quinases Reguladas por Sinal Extracelular/imunologia , Histiocitose de Células de Langerhans/imunologia , Regressão Neoplásica Espontânea/imunologia , Neoplasias Cutâneas/imunologia , Administração Cutânea , Biópsia , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Glucocorticoides/administração & dosagem , Histiocitose de Células de Langerhans/congênito , Histiocitose de Células de Langerhans/tratamento farmacológico , Histiocitose de Células de Langerhans/patologia , Humanos , Lactente , Células de Langerhans/imunologia , Células de Langerhans/patologia , Masculino , Fosforilação/imunologia , Pele/citologia , Pele/imunologia , Pele/patologia , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA